Search
Recursion Pharmaceuticals Inc
RXRXAdd to Watchlist
3.230USD
+0.120+3.86%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.71BMarket Cap
LossP/E TTM
Recursion Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Recursion Pharmaceuticals Inc is 6.19, ranking 355 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.78, which is -33.32% below the recent high of -1.86 and -310.68% above the recent low of -11.43.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
